Influence of infant gut microbiome and breastmilk HMOs on neurodevelopment in children exposed to HIV
Influence of infant gut microbiome and breastmilk HMOs on neurodevelopment in children exposed to HIV
批准号:
10381036
负责人:
SARAH F. BENKI-NUGENT
金额:
$68.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-09 至 2025-08-31
关键词:
Africa South of the SaharaAgeAge-MonthsAnimal ModelAntibioticsAttentionBindingBiologicalBirthBrainBreast FeedingChildClinical TrialsCognitionCognitiveComplementDataDevelopmentDrug ExposureEpithelial CellsExhibitsExposure toFoodFutureGeneral PopulationGrowthHIVHIV InfectionsHealthHearingHumanHuman MilkImmuneImmunomodulatorsImmunosuppressionImpairmentInfantInfant HealthInflammatoryInfluentialsInformal Social ControlInterventionLactationLanguageLinkLiteratureLongitudinal cohortMemoryMilkMother-to-child HIV transmissionMotorMotor SkillsOligosaccharidesOutcomePatternPharmaceutical PreparationsPolysaccharidesPopulationPopulations at RiskPregnant WomenProspective StudiesResource-limited settingRiskSchool-Age PopulationSupplementationTestingViralWomanantiretroviral therapybacteriomeco-infectioncognitive abilitycohortearly childhoodenteric pathogenexecutive functionfeedinggastrointestinal epitheliumgut inflammationgut microbiomegut microbiotaimprovedinfancyinfant gut microbiomeinfant morbiditymicrobiomemicrobiome alterationmicrobiome compositionneurodevelopmentnovelpathogenprebioticsprocessing speedprospectivesample collectionskills
中文摘要
摘要
普遍的孕产妇抗逆转录病毒疗法(检测和治疗和选择B Plus)的出现已有很大改善
暴露于艾滋病毒但未感染(HEU)的儿童的健康、发展和生存前景
以每年150万的速度增长。然而,这些领域的糟糕结果一直存在,并在根本上
机制尚不清楚,尤其是神经发育的机制。最近关于出生和婴儿的前瞻性研究
队列研究表明,在运动、语言和认知结果方面存在轻度到中度的神经发育折衷。
这项研究将研究感染HEU和HIV的儿童的神经发育情况。
撒哈拉以南非洲未暴露未感染(HUU)(SSA)。此外,我们还将研究看似合理和潜在的
可修改的机制,包括肠道微生物群和母乳成分的变化。恰如其分
在婴儿期建立健康的肠道微生物群越来越被认为对大脑有影响
发展。婴儿肠道微生物群可能会受到许多与HEU儿童相关的因素的影响,
包括母亲接触药物和健康状况不佳、婴儿接触抗生素、喂养做法和母乳
组成。最近的研究表明,HEU婴儿肠道微生物组的组成和图谱存在差异。
孩子们与他们年龄匹配的HUU同龄人。某些母乳的形态和浓度
寡糖,这是一种非营养性的多糖,可以作为益生菌、病原体阻滞剂或
免疫调节剂在感染艾滋病毒的哺乳期妇女中也可能有所不同。一定的战略重点
作为益生元的补充食品和使用特定HMO的母乳补充提供了两种
为HEU儿童提供有希望的干预途径,也是可能使其他部分受益的战略
处于神经发育不良结果风险的普通人群。这个新颖的项目将利用正在进行的
对HEU和HEU中的肠道微生物组和母乳HMO谱进行详细系列样本收集的队列
胡家的孩子。在目标1中,我们将比较运动、语言、认知、自我调节和执行功能技能
在24个月和36个月的HEU和HUU儿童中,告知艾滋病毒暴露对
童年早期。在目标2中,我们将研究这些结果与早期婴儿肠道微生物群之间的关系。
多样性和组成,并将增加关于早期婴儿肠道微生物组变化和
艾滋病毒内外的神经发育。在目标3中,我们将考察
特定HMO的浓度和神经发育结果,并将直接为确定和
测试候选保健组织补充剂,以促进婴儿健康和生长。该项目将产生关键的
为在SSA和其他低资源环境中使用以改进开发的未来临床试验提供信息的证据
在高浓缩铀儿童方面,以及补充促进母乳喂养的现有努力的战略。
英文摘要
ABSTRACT
The advent of universal maternal antiretroviral therapy (test and treat and Option B Plus) has vastly improved
health, development, and survival prospects for children exposed to HIV but uninfected (HEU), a population that
grows by 1.5 million each year. However, poor outcomes in these domains have persisted, and underlying
mechanisms remain unclear, particularly for neurodevelopment. Recent prospective studies of birth and infant
cohorts suggest mild to moderate neurodevelopmental compromise in motor, language and cognitive outcomes.
This study will examine neurodevelopment in a unique longitudinal cohort of children with HEU versus HIV
unexposed uninfected (HUU) in sub-Saharan Africa (SSA). Additionally, we will examine plausible and potentially
modifiable mechanisms, including alterations in the gut microbiome and breastmilk composition. Proper
establishment of a healthy gut microbiome in infancy is increasingly recognized as influential for brain
development. The infant gut microbiome could be compromised by numerous factors relevant for HEU children,
including maternal drug exposure and poor health, infant antibiotic exposure, feeding practice, and breastmilk
composition. Recent studies suggest differences in composition and profile of the infant gut microbiome in HEU
children vs. their age-matched HUU counterparts. Profile and concentration of certain human milk
oligosaccharides, which are nonnutritive glycans that can function as prebiotics, as pathogen blockers, or as
immune modulators, may also differ in lactating women infected with HIV. Strategic emphasis of certain
complementary foods as prebiotics and supplementation of human breastmilk using specific HMOs offer two
promising avenues for intervention for HEU children and are strategies that may also benefit other subsets of
the general population at risk for poor neurodevelopmental outcomes. This novel project will leverage an ongoing
cohort with detailed serial specimen collection for gut microbiome and breastmilk HMO profile in both HEU and
HUU children. In Aim 1, we will compare motor, language, cognition, self-regulation and executive function skills
in HEU vs HUU children at 24 and 36 months to inform on the impact of HIV exposure on neurodevelopment in
early childhood. In Aim 2, we will examine the relation between these outcomes and early infant gut microbiome
diversity and composition, and will add to still nascent literature on early infant gut microbiome changes and
neurodevelopment both in and outside the context of HIV. In Aim 3, we will examine the relation between
concentration of specific HMOs and neurodevelopmental outcomes, and will directly inform efforts to identify and
test candidate HMO supplements for promoting infant health and growth. This project will generate critical
evidence to inform future clinical trials for use in SSA and other low-resource settings to improve development
in HEU children and strategies to complement existing efforts to promote breastfeeding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mHealth OAE: Towards Universal Newborn Hearing Screening in Kenya (mTUNE)
-
批准号:10738905
-
项目类别:
-
资助金额:$14.79万
-
财政年份:2023
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Measurement and Analytics Core
-
批准号:10381034
-
项目类别:
-
资助金额:$89.35万
-
财政年份:2022
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Air Pollution Exposures in Early Life and Brain Development in Children
-
批准号:10405564
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2020
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Air Pollution Exposures in Early Life and Brain Development in Children
-
批准号:10247810
-
项目类别:
-
资助金额:$55.78万
-
财政年份:2020
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Air Pollution Exposures in Early Life and Brain Development in Children
-
批准号:10053545
-
项目类别:
-
资助金额:$57.41万
-
财政年份:2020
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Air Pollution Exposures in Early Life and Brain Development in Children
-
批准号:10630912
-
项目类别:
-
资助金额:$53.61万
-
财政年份:2020
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Impact of HIV, immune activation, and ART on child neurodevelopment in Kenya
-
批准号:8514745
-
项目类别:
-
资助金额:$16.98万
-
财政年份:2012
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Impact of HIV, immune activation, and ART on child neurodevelopment in Kenya
-
批准号:8889731
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2012
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
Impact of HIV, immune activation, and ART on child neurodevelopment in Kenya
-
批准号:8410048
-
项目类别:
-
资助金额:$17.08万
-
财政年份:2012
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
MINORITY PREDOCTROL FELLOWSHIP PROGRAM
-
批准号:6402658
-
项目类别:
-
资助金额:$2.36万
-
财政年份:2001
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
MINORITY PREDOCTROL FELLOWSHIP PROGRAM
-
批准号:6642041
-
项目类别:
-
资助金额:$2.76万
-
财政年份:2000
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
MINORITY PREDOCTROL FELLOWSHIP PROGRAM
-
批准号:6526010
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2000
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
MINORITY PREDOCTROL FELLOWSHIP PROGRAM
-
批准号:6314275
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2000
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
MINORITY PREDOCTROL FELLOWSHIP PROGRAM
-
批准号:6786688
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2000
-
负责人:SARAH F. BENKI-NUGENT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: